Business Description
Eurofins Scientific SE
ISIN : FR0014000MR3
Total Employee Number:
65,000Compare
Compare
Traded in other countries / regions
ERF.France0MV5.UKERFSF.USAESF.AustriaESF0.Germany IPO Date
2021-11-17Description
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.98 | |||||
Debt-to-EBITDA | 2.89 | |||||
Interest Coverage | 5.21 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.44 | |||||
Beneish M-Score | -2.94 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.1 | |||||
3-Year EBITDA Growth Rate | 3.1 | |||||
3-Year EPS without NRI Growth Rate | 5.4 | |||||
3-Year FCF Growth Rate | 8.1 | |||||
3-Year Book Growth Rate | 1.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 11.24 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.79 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.07 | |||||
9-Day RSI | 64.76 | |||||
14-Day RSI | 63.29 | |||||
3-1 Month Momentum % | -5.77 | |||||
6-1 Month Momentum % | -1.85 | |||||
12-1 Month Momentum % | 0.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.09 | |||||
Quick Ratio | 1.03 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 22.06 | |||||
Days Sales Outstanding | 54.38 | |||||
Days Payable | 103.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.04 | |||||
Dividend Payout Ratio | 0.15 | |||||
3-Year Dividend Growth Rate | -15.7 | |||||
Forward Dividend Yield % | 1.04 | |||||
5-Year Yield-on-Cost % | 1.04 | |||||
3-Year Average Share Buyback Ratio | 2.8 | |||||
Shareholder Yield % | -0.24 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.12 | |||||
Operating Margin % | 11.22 | |||||
Net Margin % | 6.51 | |||||
EBITDA Margin % | 21.03 | |||||
FCF Margin % | 7.73 | |||||
OCF Margin % | 19.17 | |||||
ROE % | 9.81 | |||||
ROA % | 4.39 | |||||
ROIC % | 6.4 | |||||
3-Year ROIIC % | -1.59 | |||||
ROC (Joel Greenblatt) % | 31.36 | |||||
ROCE % | 9.42 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 27.2 | |||||
Forward PE Ratio | 18.98 | |||||
PE Ratio without NRI | 17.88 | |||||
Shiller PE Ratio | 31.09 | |||||
Price-to-Owner-Earnings | 19.36 | |||||
PEG Ratio | 22.35 | |||||
PS Ratio | 1.77 | |||||
PB Ratio | 2.7 | |||||
Price-to-Free-Cash-Flow | 22.91 | |||||
Price-to-Operating-Cash-Flow | 9.22 | |||||
EV-to-EBIT | 19.33 | |||||
EV-to-Forward-EBIT | 19.61 | |||||
EV-to-EBITDA | 10.22 | |||||
EV-to-Forward-EBITDA | 10.96 | |||||
EV-to-Revenue | 2.15 | |||||
EV-to-Forward-Revenue | 2.07 | |||||
EV-to-FCF | 27.8 | |||||
Price-to-GF-Value | 1.03 | |||||
Price-to-Projected-FCF | 1.19 | |||||
Price-to-Median-PS-Value | 0.77 | |||||
Earnings Yield (Greenblatt) % | 5.17 | |||||
FCF Yield % | 4.7 | |||||
Forward Rate of Return (Yacktman) % | 5.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eurofins Scientific SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 7,296.1 | ||
| EPS (TTM) (€) | 2.55 | ||
| Beta | 1.8048 | ||
| 3-Year Sharpe Ratio | 0.08 | ||
| 3-Year Sortino Ratio | 0.12 | ||
| Volatility % | 22.37 | ||
| 14-Day RSI | 63.29 | ||
| 14-Day ATR (€) | 1.11581 | ||
| 20-Day SMA (€) | 65.833 | ||
| 12-1 Month Momentum % | 0.2 | ||
| 52-Week Range (€) | 55.8 - 73.22 | ||
| Shares Outstanding (Mil) | 173.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eurofins Scientific SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eurofins Scientific SE Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-07-23 15:00 | In 19 days | ||
| Second quarter earnings results for 2026 | 2026-07-23 | In 18 days | ||
| EUR 0.720000 Cash Dividend | 2026-04-28 | 61.48 (-1.32%) | ||
| General meeting for 2026 | 2026-04-23 15:30 | 63.04 (+1.29%) | ||
| First quarter earnings conference call for 2026 | 2026-04-22 15:00 | 69.60 (-0.57%) | ||
| First quarter earnings results for 2026 | 2026-04-22 | 69.60 (-0.57%) | ||
| Annual report for 2025 | 2026-02-26 | 68.56 (+1.66%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-01-29 09:00 | 69.84 (-1.33%) | ||
| Fourth quarter earnings results for 2025 | 2026-01-29 | 69.84 (-1.33%) | ||
| Second quarter earnings conference call for 2025 | 2025-07-23 15:00 | 61.70 (+0.10%) |
Show
Entries
Eurofins Scientific SE Frequently Asked Questions
What is Eurofins Scientific SE(XTER:ESF0)'s stock price today?
The current price of XTER:ESF0 is €69.20. The 52 week high of XTER:ESF0 is €73.22 and 52 week low is €55.80.
When is next earnings date of Eurofins Scientific SE(XTER:ESF0)?
The next earnings date of Eurofins Scientific SE(XTER:ESF0) is 2026-07-23 Est..
Does Eurofins Scientific SE(XTER:ESF0) pay dividends? If so, how much?
The Dividend Yield %  of Eurofins Scientific SE(XTER:ESF0) is 1.04% (As of Today), Highest Dividend Payout Ratio of Eurofins Scientific SE(XTER:ESF0) was 0.35. The lowest was 0.11. And the median was 0.14. The  Forward Dividend Yield % of Eurofins Scientific SE(XTER:ESF0) is 1.04%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Eurofins Scientific SE
No articles.